ShangBay Capital
Palo Alto, Californiashangbaycapital.com
Overview
ShangBay Capital is a leading venture capital firm based in the heart of innovation that brings investors access to best-in-class investments within the medical device, biotechnology, and healthcare technology sectors through venture equity participation . The firm specializes in disruptive technologies for unmet clinical needs, partnering with top teams and leveraging industry expertise and strategic connections to access high-quality deals and drive success .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nervonik | Apr 2026 | Series B | Co-investor |
| Petal Surgical | Oct 2025 | Series A | Co-investor |
| SetPoint Medical | Aug 2025 | Series D | Co-investor |
| SetPoint Medical | Aug 2025 | Series C Extension | Co-investor |
| Evident Vascular | Mar 2025 | Series B | Co-investor |
Key People
William Dai
Founding Managing Partner
Michael P. Wallace
Venture Partner
Ava Rose Nishime
Venture Capital Investment Intern
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
